Rituximab (Redditux) is available in 10 mL vial containing 100 mg of Rituximab (r-DNA origin) or 50 mL vial containing 500 mg of Rituximab (r-DNA origin).
Active substance: Rituximab (r-DNA origin).
Rituximab is a genetically engineered mouse-human chimeric monoclonal antibody representing a glycosylated immunoglobulin that contains murine light and heavy chain variable regions and human IgG1 constant region sequences. The antibody is produced by mammalian (Chinese hamster ovary) cell suspension culture and purified by affinity and ion exchange chromatographies, including specific viral inactivation and removal procedures.
Excipients with known effects: This medicinal product contains less than 1mmol sodium per dose, i.e. essentially sodium free.
Excipients/Inactive Ingredients: Sodium citrate, Polysorbate 80, Sodium chloride, Water for injection.